Early Transcriptomic Signatures of Immune Response Modulation Following Antiretroviral Therapy in HIV-Infected Patients
Authors:
- Ekaterina A. StolbovaESEkaterina A. Stolbova
- Anastasia V. PokrovskayaAPAnastasia V. Pokrovskaya
- Andrey B. ShemshuraASAndrey B. Shemshura
- Dmitry E. KireevDKDmitry E. Kireev
- Alexey A. LaguninALAlexey A. Lagunin
- Boris N. SobolevBSBoris N. Sobolev
- Sergey M. IvanovSISergey M. Ivanov
- Olga A. TarasovaOTOlga A. Tarasova
Open Access
- 2 November 2025
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (21) , 10678
Abstract
Human immunodeficiency virus (HIV) remains a global public health challenge. Antiretroviral therapy (ART) improves outcomes by suppressing viral replication and enabling immune recovery, yet the early molecular mechanisms of immune-related transcriptional change after ART remain insufficiently characterized. We enrolled eight ART-naïve male patients with HIV aged 18–35. Peripheral blood mononuclear cells (PBMCs) were collected before and after 24 weeks of combination ART (TDF, 3TC, DTG) and underwent bulk RNA-seq (Illumina HiSeq 1500, Illumina, Inc., San Diego, CA, USA). Differential expression was assessed with DESeq2 (paired design); gene set enrichment analysis (GSEA), principal component analysis (PCA), hierarchical clustering, and protein–protein interaction (PPI) networks (STRING/NetworkX) explored functional patterns and transcriptomic shifts. We identified 87 differentially expressed genes, including 67 downregulated interferon-stimulated genes (e.g., IFI44L, ISG15, STAT1) and 20 upregulated transcripts, mostly pseudogenes related to ribosomal proteins. Functional enrichment revealed suppression of type I interferon and other antiviral signaling pathways. PCA and hierarchical clustering indicated a post-ART transcriptional shift. These findings suggest that early immune recovery following ART involves downregulation of chronic interferon-driven activation. This observation may correspond to partial restoration of T-cell functional capacity, reduced immune exhaustion, and a rebalanced antiviral immune environment.Keywords
Funding Information
- Program for Basic Research in the Russian Federation (124050800018-9)
This publication has 83 references indexed in Scilit:
- Genome‐wide profiling of N6‐methyladenosine‐modified pseudogene‐derived long noncoding RNAs reveals the tumour‐promoting and innate immune‐restraining function of RPS15AP12 in ovarian cancerClinical and Translational Medicine, 2025
- Impact of interrupting antiretroviral therapy started during primary HIV-1 infection on plasma neurofilament light chain protein, a marker of neuronal injury: The SPARTAC trialJournal of Virus Eradication, 2024
- Sustained type I interferon signaling after human immunodeficiency virus type 1 infection of human iPSC derived microglia and cerebral organoidsiScience, 2024
- The pseudogenes of eukaryotic translation elongation factors (EEFs): Role in cancer and other human diseasesGenes & Diseases, 2021
- SERPING1 mRNA overexpression in monocytes from HIV+ patientsInflammation Research, 2017
- ISG15 expression correlates with HIV-1 viral load and with factors regulating T cell responseImmunobiology, 2016
- Host, disease, and antiretroviral factors are associated with normalization of the CD4:CD8 ratio after initiating antiretroviral therapyJournal of Allergy and Clinical Immunology, 2015
- Type I Interferon: Understanding Its Role in HIV Pathogenesis and TherapyCurrent HIV/AIDS Reports, 2015
- Differential gene expression in HIV-infected individuals following ARTAntiviral Research, 2013
- Generation of a pseudogene during retroviral infectionMammalian Genome, 1995